Endoplasmic Reticulum Stress in Diseases journal is undergoing reorganization, and it is temporarily closed for new submissions. It will be re-launched in 2020 with the new title and scope dedicated to cellular pathology.
The journal Endoplasmic Reticulum Stress in Diseases (ERSD) focuses on the biology of endoplasmic reticulum (ER) stress and its impact on the development and progression of various human disorders ranging from carcinogenesis and inflammation to metabolic and neurodegenerative diseases. The journal welcomes both in vitro and in vivo studies that contribute to the understanding of the pathophysiology and the development of novel therapeutics to relevant diseases.
The journal focuses on the latest insights to the roles of the ER stress in the development and progression of relevant human pathological conditions. Involvement of ER stress in human diseases is a fast growing field with tremendous potential to identify novel drug targets. However, most of the work is scattered in various journals dealing with specific diseases. The primary mission of ERSD is to become a central publication venue for all members of the research community working on different aspects of ER function and malfunction in pathogenesis of human diseases, in order to ensure more efficient and productive exchange of research ideas, technologies and therapeutic options.
ERSD is an open access, peer-reviewed journal. The journal is led by an Editorial Board of the internationally recognized scientists, and publishes up-to-date research, commentaries and leading reviews.
Authors benefit from
fast, fair and constructive peer review
articles placed on-line within 10 days of acceptance and proofing
language editing service for accepted articles
no limit on article length or the number of color figures
authors allowed to retain copyright to their work
waiver of publications charges up till 2017
Abstracting & Indexing
Endoplasmic Reticulum Stress in Diseases is covered by the following services:
Chemical Abstracts Service (CAS) - CAplus
Chemical Abstracts Service (CAS) - SciFinder
CNKI Scholar (China National Knowledge Infrastructure)
CNPIEC - cnpLINKer
EBSCO (relevant databases)
EBSCO Discovery Service
KESLI-NDSL (Korean National Discovery for Science Leaders)
contain original work - not published elsewhere in any medium (in the whole or in part) by the authors or anyone else and not under consideration for publication in any other medium;
focus on the aims and scope of the journal;
be clearly and correctly written - should contain all essential features of a scientific publication that is easy to understand for the target audience;
written in English - attention to detail of the language will avoid severe misunderstandings which might lead to rejection of the paper;
be delivered in electronic format.
The journal accepts the following publication formats:
Communications and Rapid Communications
Reviews and Mini-Reviews
Letters to the Editor and Amendments
It is important that authors include a cover letter with their manuscript. Please explain why you consider your manuscript as suitable for publication in the journal, why will your paper inspire the other members of your field, and how will it drive research forward. The letter should contain all important details such as:
your full name (submitted by)
full title of article and short title
full list of authors with affiliations
e-mail of the corresponding author
contact address, telephone/fax numbers of the corresponding author
number of attached files, if there is more than one
status: new, reviewed or accepted (with reference ID if reviewed or accepted)
Cover letter should explicitly state that the manuscript (or one with substantially the same content, by any of the authors) has not been previously published in any language anywhere and that it is not under simultaneous consideration or in press by another journal. If related work has been submitted, then we may require a preprint to be made available. Reviewers will be asked to comment on the overlap between the related submissions.
Manuscripts that have been previously rejected, or withdrawn after being returned for modification, may be resubmitted if the major criticisms have been addressed. The cover letter must state that the manuscript is a resubmission, and the former manuscript number should be provided.
Conflict of interest declaration To ensure fair and objective decision-making, authors must declare any associations that pose a conflict of interest in connection with evaluated manuscripts (see Editorial Policy for details). Authors are encouraged to fill in the ICMJE Conflicts of Interest Form (available here) and send it in the electronic format to the Journal Editor.
Open Access License Authors have to sign an Open Access License that is available on the journal webpage. We encourage the authors to send the signed license along with the manuscript. Please note, that no article will be published unless the Open Access License is signed.
Formatting Requirements We accept submission of text, tables and figures as separate files or as a composite file. For your initial submission, we recommend you upload your entire manuscript, including tables and figures, as a single PDF file. If you are invited to submit a revised manuscript, please provide us with individual files: an editable text and publication-quality figures.
Text files can be submitted in the following formats: MS Word - standard DOCUMENT (.DOC) or RICH TEXT FORMAT (.RTF); PDF (not applicable for re-submitted or accepted manuscripts, see below)
Tables should be submitted as MS Word or PDF (not applicable for re-submitted or accepted manuscripts, see below). Please note that a straight Excel file is not an acceptable format
Graphics files can be submitted in any of the following graphic formats: EPS; BMP; JPG; TIFF; GIF or PDF. Please note that Powerpoint files are not accepted
Post acceptance, text files of the revised manuscript and tables are required for use in the production.
Authors should clearly indicate location of tables and figures in the text if these elements are given separately or at the end of the manuscript. If this information is not provided to the editorial office, we will assume that they should be left at the end of the text.
For further instructions, please carefully follow the guidelines described in Instructions for Authors.
Journal Editor Anna Blumental-Perry, Case Western Reserve University, USA
Co-Editor X. Robert Wang, Samford University, USA
Associate Editor Cristina Scapin, San Raffaele Scientific Institute, Italy
Editorial Advisory Board Simone Cenci, San Raffaele Scientific Institute, Italy Eric Chevet, University of Bordeaux, France Julio A. Aguirre-Ghiso, The Mount Sinai School of Medicine, USA Maurizio Grimaldi, Southern Research Institute, USA Peter Hersey, The University of Sydney, Australia Guido Kroemer, University of Paris Descartes, France Guang Liang, Wenzhou Medical College, China Bo Lu, Thomas Jefferson University, USA Yasuyuki Nomura, Yokohama College of Pharmacy, Japan Matthias Ocker, Bayer Healthcare Pharmaceuticals and Charite University Medicine Berlin, Germany Erik Lee Snapp, Albert Einstein College of Medicine, USA Boaz Tirosh, The Hebrew University of Jerusalem, Israel Danyelle M. Townsend, University of South Carolina, USA Maurizio Zanetti, University of California San Diego, USA
Editorial Review Board Hiderou Yoshida, University of Hyogo, Japan Matteo Landriscina, University of Foggia, Italy Frank Thévenod, University of Witten-Herdecke, Germany Franca Esposito, University of Naples Federico II, Italy Chris. P. F. Redfern, Newcastle University, United Kingdom Rahul Srinivasan, Texas A&M University, USA Marek Michalak, University of Alberta, Canada Yasuyuki Nomura, Kurume University School of Medicine, Japan Robert Clarke, Georgetown University, USA Prakash Kulkarni, University of Maryland, USA Makoto Miyazaki, University of Colorado Anschutz Medical Center, USA Matthias Ocker, Bayer Healthcare Pharmaceuticals and Charite University Medicine Berlin, Germany David Perlmutter, Washington University School of Medicine, USA Jonathan Lin, UC San Diego, USA Yihong Ye, National Institute of Diabetes, Digestive & Kidney Diseases, USA Muthuswamy Balasubramanyam, Madras Diabetes Research Foundation, Gopalapuram, Chennai, India Nicolas Bousette, Universite de Montreal, Canada Jozsef Mandl, Semmelweis University, Hungary Frédéric Gachon, Nestle Institute of Health Sciences, Switzerland
Assistant Editors Flavia Zita Francies, University of the Witwatersrand, South Africa Celeste Manfredonia, University Hospital of Basel, Switzerland
Language Editors Andrew Degar, Baylor College of Medicine, USA Caryn Nelson, City of Savannah, USA
Publisher DE GRUYTER Poland Bogumiła Zuga 32A Str. 01-811 Warsaw, Poland T: +48 22 701 50 15